News
Each time a cell divides, a small section of each chromosome's protective cap—the telomere—is worn away. Most cells use an ...
A cancer immunotherapy may slow Parkinson’s disease by blocking the spread of harmful brain proteins, Johns Hopkins researchers found.
Inhibiting an overabundant enzyme saved a key component of a brain signaling pathway that is vital for motor control in a ...
A 12-month study found that Ambroxol helped stabilised psychiatric symptoms and protected against brain damage in genetically ...
Putting the brakes on an enzyme might rescue neurons that are dying due to a type of Parkinson's disease that's caused by a ...
Inhibition of LKKR2 may rescue neurons that are dying due to a type of Parkinson’s disease that is caused by a single genetic ...
A clinical trial has revealed that Ambroxol, a common cough medicine in Europe, may help slow cognitive decline in people with Parkinson’s disease dementia.
The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.
Putting the brakes on an enzyme might rescue neurons that are dying due to a type of Parkinson's disease that's caused by a ...
A COMMON cough medicine could help protect against dementia. A study found that it prevented people with Parkinson’s develop ...
A commonly sold cough syrup in Europe could potentially slow down progression of dementia in patients with Parkinson’s ...
Scientists discover that dental pulp stem cells from wisdom teeth could regenerate neurons and bones and offer treatments for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results